This inventor holds 2 USPTO granted patents. Top assignee: Merck Frosst Canada, Inc.. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of Mohammed Adam
Introduction
Mohammed Adam is an accomplished inventor based in Kirkland, CA. He has made significant contributions to the field of biotechnology, particularly in the area of prostaglandin receptors. With a total of 2 patents to his name, Adam continues to push the boundaries of scientific research and innovation.
Latest Patents
One of Mohammed Adam's latest patents involves the identification of a novel prostaglandin receptor, EP2. This patent details the DNA encoding the human prostaglandin receptor EP2, which has been isolated, purified, sequenced, and expressed in host cells. The DNA encoding this novel receptor, along with the host cells expressing it, is utilized to identify modulators of the prostaglandin receptor, showcasing Adam's innovative approach to biotechnology.
Career Highlights
Adam is currently employed at Merck Frosst Canada, Inc., where he collaborates with other talented professionals in the field. His work at Merck has allowed him to contribute to groundbreaking research and development in pharmaceuticals and biotechnology.
Collaborations
Some of his notable coworkers include Mark Abramovitz and Lison Bastien. Their collaborative efforts have further enhanced the research environment at Merck, leading to advancements in their respective fields.
Conclusion
In summary, Mohammed Adam is a notable inventor whose work in prostaglandin receptors has the potential to impact the field of biotechnology significantly. His contributions, along with his collaborations, continue to drive innovation forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile